Chinese registry of rheumatoid arthritis (CREDIT) V: sex impacts rheumatoid arthritis in Chinese patients
The impact of sex on the clinical manifestations of rheumatoid arthritis (RA) were diversely reported in the literature. The Chinese Registry of rhEumatoiD arthrITis provides a platform for the investigation of this issue in Chinese patients. Demographic and clinical parameters were collected from a...
Saved in:
Cover
Loading…
| Abstract | The impact of sex on the clinical manifestations of rheumatoid arthritis (RA) were diversely reported in the literature. The Chinese Registry of rhEumatoiD arthrITis provides a platform for the investigation of this issue in Chinese patients.
Demographic and clinical parameters were collected from all enrolled patients with RA and from patients with early RA (disease duration ≤6 months). The differences in data regarding disease activity, comorbidities, and medications for RA were compared between men and women. The proportions of patients who achieved remission and low disease activity were compared at enrollment and during 3-, 6-, and 12-month follow-up visits.
A total of 11,564 patients were enrolled, 83.6% of whom were female. In all the enrolled patients and patients with early RA, C-reactive protein (CRP, 12.0 vs . 6.7 mg/L), pain visual analogue scale (4.8 vs . 4.5), patient's and physician's global assessment (4.9 vs . 4.5 and 4.9 vs . 4.5), 28-joint disease activity score using DAS28-CRP (4.3 vs . 4.0) simplified disease activity index (21.9 vs . 19.9), and clinical disease activity index (19.3 vs . 18.0) were significantly higher in men than in women. Additionally, the swollen joint count/tender joint count and DAS28 using erythrocyte sedimentation rate were higher in male patients than in female patients with early RA. More female patients with early RA reached the treatment target at baseline than male patients (23.4% vs . 18.2%, assessed by CDAI). At 3 months, 6 months, and 12 months, the proportion of remission and treatment target achievement was similar in both sexes. Coronary artery disease (CAD) and stroke were more frequent in men than in women.
In Chinese patients with RA, men were found to have more active disease, as well as more cases of CAD and stroke. Therefore, sex should be carefully considered during the personalization of RA treatment. |
|---|---|
| AbstractList | The impact of sex on the clinical manifestations of rheumatoid arthritis (RA) were diversely reported in the literature. The Chinese Registry of rhEumatoiD arthrITis provides a platform for the investigation of this issue in Chinese patients.BACKGROUNDThe impact of sex on the clinical manifestations of rheumatoid arthritis (RA) were diversely reported in the literature. The Chinese Registry of rhEumatoiD arthrITis provides a platform for the investigation of this issue in Chinese patients.Demographic and clinical parameters were collected from all enrolled patients with RA and from patients with early RA (disease duration ≤6 months). The differences in data regarding disease activity, comorbidities, and medications for RA were compared between men and women. The proportions of patients who achieved remission and low disease activity were compared at enrollment and during 3-, 6-, and 12-month follow-up visits.METHODSDemographic and clinical parameters were collected from all enrolled patients with RA and from patients with early RA (disease duration ≤6 months). The differences in data regarding disease activity, comorbidities, and medications for RA were compared between men and women. The proportions of patients who achieved remission and low disease activity were compared at enrollment and during 3-, 6-, and 12-month follow-up visits.A total of 11,564 patients were enrolled, 83.6% of whom were female. In all the enrolled patients and patients with early RA, C-reactive protein (CRP, 12.0 vs . 6.7 mg/L), pain visual analogue scale (4.8 vs . 4.5), patient's and physician's global assessment (4.9 vs . 4.5 and 4.9 vs . 4.5), 28-joint disease activity score using DAS28-CRP (4.3 vs . 4.0) simplified disease activity index (21.9 vs . 19.9), and clinical disease activity index (19.3 vs . 18.0) were significantly higher in men than in women. Additionally, the swollen joint count/tender joint count and DAS28 using erythrocyte sedimentation rate were higher in male patients than in female patients with early RA. More female patients with early RA reached the treatment target at baseline than male patients (23.4% vs . 18.2%, assessed by CDAI). At 3 months, 6 months, and 12 months, the proportion of remission and treatment target achievement was similar in both sexes. Coronary artery disease (CAD) and stroke were more frequent in men than in women.RESULTSA total of 11,564 patients were enrolled, 83.6% of whom were female. In all the enrolled patients and patients with early RA, C-reactive protein (CRP, 12.0 vs . 6.7 mg/L), pain visual analogue scale (4.8 vs . 4.5), patient's and physician's global assessment (4.9 vs . 4.5 and 4.9 vs . 4.5), 28-joint disease activity score using DAS28-CRP (4.3 vs . 4.0) simplified disease activity index (21.9 vs . 19.9), and clinical disease activity index (19.3 vs . 18.0) were significantly higher in men than in women. Additionally, the swollen joint count/tender joint count and DAS28 using erythrocyte sedimentation rate were higher in male patients than in female patients with early RA. More female patients with early RA reached the treatment target at baseline than male patients (23.4% vs . 18.2%, assessed by CDAI). At 3 months, 6 months, and 12 months, the proportion of remission and treatment target achievement was similar in both sexes. Coronary artery disease (CAD) and stroke were more frequent in men than in women.In Chinese patients with RA, men were found to have more active disease, as well as more cases of CAD and stroke. Therefore, sex should be carefully considered during the personalization of RA treatment.CONCLUSIONSIn Chinese patients with RA, men were found to have more active disease, as well as more cases of CAD and stroke. Therefore, sex should be carefully considered during the personalization of RA treatment. The impact of sex on the clinical manifestations of rheumatoid arthritis (RA) were diversely reported in the literature. The Chinese Registry of rhEumatoiD arthrITis provides a platform for the investigation of this issue in Chinese patients. Demographic and clinical parameters were collected from all enrolled patients with RA and from patients with early RA (disease duration ≤6 months). The differences in data regarding disease activity, comorbidities, and medications for RA were compared between men and women. The proportions of patients who achieved remission and low disease activity were compared at enrollment and during 3-, 6-, and 12-month follow-up visits. A total of 11,564 patients were enrolled, 83.6% of whom were female. In all the enrolled patients and patients with early RA, C-reactive protein (CRP, 12.0 vs . 6.7 mg/L), pain visual analogue scale (4.8 vs . 4.5), patient's and physician's global assessment (4.9 vs . 4.5 and 4.9 vs . 4.5), 28-joint disease activity score using DAS28-CRP (4.3 vs . 4.0) simplified disease activity index (21.9 vs . 19.9), and clinical disease activity index (19.3 vs . 18.0) were significantly higher in men than in women. Additionally, the swollen joint count/tender joint count and DAS28 using erythrocyte sedimentation rate were higher in male patients than in female patients with early RA. More female patients with early RA reached the treatment target at baseline than male patients (23.4% vs . 18.2%, assessed by CDAI). At 3 months, 6 months, and 12 months, the proportion of remission and treatment target achievement was similar in both sexes. Coronary artery disease (CAD) and stroke were more frequent in men than in women. In Chinese patients with RA, men were found to have more active disease, as well as more cases of CAD and stroke. Therefore, sex should be carefully considered during the personalization of RA treatment. Background::The impact of sex on the clinical manifestations of rheumatoid arthritis (RA) were diversely reported in the literature. The Chinese Registry of rhEumatoiD arthrITis provides a platform for the investigation of this issue in Chinese patients.Methods::Demographic and clinical parameters were collected from all enrolled patients with RA and from patients with early RA (disease duration ≤6 months). The differences in data regarding disease activity, comorbidities, and medications for RA were compared between men and women. The proportions of patients who achieved remission and low disease activity were compared at enrollment and during 3-, 6-, and 12-month follow-up visits.Results::A total of 11,564 patients were enrolled, 83.6% of whom were female. In all the enrolled patients and patients with early RA, C-reactive protein (CRP, 12.0 vs. 6.7 mg/L), pain visual analogue scale (4.8 vs. 4.5), patient’s and physician’s global assessment (4.9 vs. 4.5 and 4.9 vs. 4.5), 28-joint disease activity score using DAS28-CRP (4.3 vs. 4.0) simplified disease activity index (21.9 vs. 19.9), and clinical disease activity index (19.3 vs. 18.0) were significantly higher in men than in women. Additionally, the swollen joint count/tender joint count and DAS28 using erythrocyte sedimentation rate were higher in male patients than in female patients with early RA. More female patients with early RA reached the treatment target at baseline than male patients (23.4% vs. 18.2%, assessed by CDAI). At 3 months, 6 months, and 12 months, the proportion of remission and treatment target achievement was similar in both sexes. Coronary artery disease (CAD) and stroke were more frequent in men than in women. Conclusions::In Chinese patients with RA, men were found to have more active disease, as well as more cases of CAD and stroke. Therefore, sex should be carefully considered during the personalization of RA treatment. Background:The impact of sex on the clinical manifestations of rheumatoid arthritis (RA) were diversely reported in the literature. The Chinese Registry of rhEumatoiD arthrITis provides a platform for the investigation of this issue in Chinese patients.Methods:Demographic and clinical parameters were collected from all enrolled patients with RA and from patients with early RA (disease duration ≤6 months). The differences in data regarding disease activity, comorbidities, and medications for RA were compared between men and women. The proportions of patients who achieved remission and low disease activity were compared at enrollment and during 3-, 6-, and 12-month follow-up visits.Results:A total of 11,564 patients were enrolled, 83.6% of whom were female. In all the enrolled patients and patients with early RA, C-reactive protein (CRP, 12.0 vs. 6.7 mg/L), pain visual analogue scale (4.8 vs. 4.5), patient's and physician's global assessment (4.9 vs. 4.5 and 4.9 vs. 4.5), 28-joint disease activity score using DAS28-CRP (4.3 vs. 4.0) simplified disease activity index (21.9 vs. 19.9), and clinical disease activity index (19.3 vs. 18.0) were significantly higher in men than in women. Additionally, the swollen joint count/tender joint count and DAS28 using erythrocyte sedimentation rate were higher in male patients than in female patients with early RA. More female patients with early RA reached the treatment target at baseline than male patients (23.4% vs. 18.2%, assessed by CDAI). At 3 months, 6 months, and 12 months, the proportion of remission and treatment target achievement was similar in both sexes. Coronary artery disease (CAD) and stroke were more frequent in men than in women.Conclusions:In Chinese patients with RA, men were found to have more active disease, as well as more cases of CAD and stroke. Therefore, sex should be carefully considered during the personalization of RA treatment. |
| Abstract_FL | Background::The impact of sex on the clinical manifestations of rheumatoid arthritis (RA) were diversely reported in the literature. The Chinese Registry of rhEumatoiD arthrITis provides a platform for the investigation of this issue in Chinese patients.Methods::Demographic and clinical parameters were collected from all enrolled patients with RA and from patients with early RA (disease duration ≤6 months). The differences in data regarding disease activity, comorbidities, and medications for RA were compared between men and women. The proportions of patients who achieved remission and low disease activity were compared at enrollment and during 3-, 6-, and 12-month follow-up visits.Results::A total of 11,564 patients were enrolled, 83.6% of whom were female. In all the enrolled patients and patients with early RA, C-reactive protein (CRP, 12.0
vs. 6.7 mg/L), pain visual analogue scale (4.8
vs. 4.5), patient’s and physician’s global assessment (4.9
vs. 4.5 and 4.9
vs. 4.5), 28-joint disease activity score using DAS28-CRP (4.3
vs. 4.0) simplified disease activity index (21.9
vs. 19.9), and clinical disease activity index (19.3
vs. 18.0) were significantly higher in men than in women. Additionally, the swollen joint count/tender joint count and DAS28 using erythrocyte sedimentation rate were higher in male patients than in female patients with early RA. More female patients with early RA reached the treatment target at baseline than male patients (23.4%
vs. 18.2%, assessed by CDAI). At 3 months, 6 months, and 12 months, the proportion of remission and treatment target achievement was similar in both sexes. Coronary artery disease (CAD) and stroke were more frequent in men than in women.
Conclusions::In Chinese patients with RA, men were found to have more active disease, as well as more cases of CAD and stroke. Therefore, sex should be carefully considered during the personalization of RA treatment. |
| Author | Li, Hongbin Fang, Yongfei Li, Mengtao Jiang, Nan Xu, Jian Li, Qin Wu, Lijun Wang, Yanhong Zhao, Cheng Tian, Xinping Jiang, Zhenyu Zeng, Xiaofeng Wang, Qian Duan, Xinwang Leng, Xiaomei |
| AuthorAffiliation | Department of Rheumatology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China Department of Epidemiology and Bio-Statistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing 100005, China Department of Rheumatology and Immunology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang 830001, China Department of Rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China Department of Rheumatology, The First Affiliated Hospital of Guangxi Medical University, Manning, Guangxi 530021, China Department of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, China Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College; National Clinical Research Center for |
| AuthorAffiliation_xml | – name: Department of Rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China – name: Department of Rheumatology and Immunology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang 830001, China – name: Department of Rheumatology, The First Affiliated Hospital of Guangxi Medical University, Manning, Guangxi 530021, China – name: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology; State Key Laboratory of Complex Severe and Rare Diseases; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China – name: Department of Rheumatology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China – name: Department of Rheumatology, The First Hospital of Jilin University, Changchun, Jilin 130021, China – name: Department of Epidemiology and Bio-Statistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing 100005, China – name: Department of Rheumatology, the Affiliated Hospital of Inner Mongolia Medical College, Hohhot, Inner Mongolia 010050, China – name: Department of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, China – name: Department of Rheumatology, the First People's Hospital of Yunnan Province, Kunming, Yunnan 650032, China – name: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology; State Key Laboratory of Complex Severe and Rare Diseases; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China%Department of Rheumatology, the First People’s Hospital of Yunnan Province, Kunming, Yunnan 650032, China%Department of Rheumatology, the Affiliated Hospital of Inner Mongolia Medical College, Hohhot, Inner Mongolia 010050, China%Department of Rheumatology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China%Department of Rheumatology and Immunology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang 830001, China%Department of Rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China%Department of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, China%Department of Rheumatology, The First Affiliated Hospital of Guangxi Medical University, Manning, Guangxi 530021, China%Department of Rheumatology, The First Hospital of Jilin University, Changchun, Jilin 130021, China%Department of Epidemiology and Bio-Statistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing 100005, China – name: 2 Department of Rheumatology, the First People's Hospital of Yunnan Province, Kunming, Yunnan 650032, China – name: 7 Department of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, China – name: 9 Department of Rheumatology, The First Hospital of Jilin University, Changchun, Jilin 130021, China – name: 10 Department of Epidemiology and Bio-Statistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing 100005, China – name: 1 Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology; State Key Laboratory of Complex Severe and Rare Diseases; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China – name: 6 Department of Rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China – name: 8 Department of Rheumatology, The First Affiliated Hospital of Guangxi Medical University, Manning, Guangxi 530021, China – name: 4 Department of Rheumatology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China – name: 3 Department of Rheumatology, the Affiliated Hospital of Inner Mongolia Medical College, Hohhot, Inner Mongolia 010050, China – name: 5 Department of Rheumatology and Immunology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang 830001, China |
| Author_FL | Fang Yongfei Jiang Nan Li Hongbin Wang Qian Li Mengtao Duan Xinwang Li Qin Leng Xiaomei Zhao Cheng Jiang Zhenyu Wang Yanhong Tian Xinping Wu Lijun Xu Jian Zeng Xiaofeng |
| Author_FL_xml | – sequence: 1 fullname: Jiang Nan – sequence: 2 fullname: Li Qin – sequence: 3 fullname: Li Hongbin – sequence: 4 fullname: Fang Yongfei – sequence: 5 fullname: Wu Lijun – sequence: 6 fullname: Duan Xinwang – sequence: 7 fullname: Xu Jian – sequence: 8 fullname: Zhao Cheng – sequence: 9 fullname: Jiang Zhenyu – sequence: 10 fullname: Wang Yanhong – sequence: 11 fullname: Wang Qian – sequence: 12 fullname: Leng Xiaomei – sequence: 13 fullname: Li Mengtao – sequence: 14 fullname: Tian Xinping – sequence: 15 fullname: Zeng Xiaofeng |
| Author_xml | – sequence: 1 givenname: Nan surname: Jiang fullname: Jiang, Nan organization: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology; State Key Laboratory of Complex Severe and Rare Diseases; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China – sequence: 2 givenname: Qin surname: Li fullname: Li, Qin organization: Department of Rheumatology, the First People's Hospital of Yunnan Province, Kunming, Yunnan 650032, China – sequence: 3 givenname: Hongbin surname: Li fullname: Li, Hongbin organization: Department of Rheumatology, the Affiliated Hospital of Inner Mongolia Medical College, Hohhot, Inner Mongolia 010050, China – sequence: 4 givenname: Yongfei surname: Fang fullname: Fang, Yongfei organization: Department of Rheumatology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China – sequence: 5 givenname: Lijun surname: Wu fullname: Wu, Lijun organization: Department of Rheumatology and Immunology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang 830001, China – sequence: 6 givenname: Xinwang surname: Duan fullname: Duan, Xinwang organization: Department of Rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China – sequence: 7 givenname: Jian surname: Xu fullname: Xu, Jian organization: Department of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, China – sequence: 8 givenname: Cheng surname: Zhao fullname: Zhao, Cheng organization: Department of Rheumatology, The First Affiliated Hospital of Guangxi Medical University, Manning, Guangxi 530021, China – sequence: 9 givenname: Zhenyu surname: Jiang fullname: Jiang, Zhenyu organization: Department of Rheumatology, The First Hospital of Jilin University, Changchun, Jilin 130021, China – sequence: 10 givenname: Yanhong surname: Wang fullname: Wang, Yanhong organization: Department of Epidemiology and Bio-Statistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing 100005, China – sequence: 11 givenname: Qian surname: Wang fullname: Wang, Qian organization: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology; State Key Laboratory of Complex Severe and Rare Diseases; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China – sequence: 12 givenname: Xiaomei surname: Leng fullname: Leng, Xiaomei organization: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology; State Key Laboratory of Complex Severe and Rare Diseases; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China – sequence: 13 givenname: Mengtao surname: Li fullname: Li, Mengtao organization: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology; State Key Laboratory of Complex Severe and Rare Diseases; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China – sequence: 14 givenname: Xinping surname: Tian fullname: Tian, Xinping organization: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology; State Key Laboratory of Complex Severe and Rare Diseases; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China – sequence: 15 givenname: Xiaofeng surname: Zeng fullname: Zeng, Xiaofeng organization: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology; State Key Laboratory of Complex Severe and Rare Diseases; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36103962$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkl9v0zAUxSM0xLrBN0AoEhIaDxn-E8fxHpBQN6DSEBIavFqOc924JHFnJ3Tj0-PQddoqHvCDLdnn_HyufY-Sg971kCQvMTrFSPB38y_iFD0YBGP0JJkRlpOMFTk-SGaIFkVWCCEOk6MQVlHDGC-eJYe0wIiKgswSO29sDwFSD0sbBn-bOpP6BsZODc7WqfJD4-1gQ3oy_3Zxvrh6m_44SwPcpLZbKz2Ef4ttn-7AazVY6IfwPHlqVBvgxd16nHz_eHE1_5xdfv20mH-4zDTjZZmJMhcl0cRUgKkWpuJcKxC0RKWAmJphTHNRAxeamboCwZiGvK44o4YC4_Q4WWy5tVMrufa2U_5WOmXl3w3nlzLmtLoFiTErUMmYEVTltTEVNgyM5krluqyZiqz3W9Z6rDqodazDq_YR9PFJbxu5dL-k4BwTISLgzRawUb1R_VKu3Oj7WL783ehuRRAhuESojMKTu5u8ux4hDLKzQUPbqh7cGCThOC9i2nxivt6T3kMJZ7nAcUJR9eph9PvMu6-PgrOtQHsXggcjtR3iX7mpEttKjOTUZzL2mdzvs2jO98w7_v_ZNq4dwIef7bgBLxtQ7dBMciIoRdn0LEgQhLLJWdI_pwHjzg |
| CitedBy_id | crossref_primary_10_1515_rir_2024_0026 crossref_primary_10_1097_CM9_0000000000003111 crossref_primary_10_3389_fmed_2024_1439182 crossref_primary_10_1007_s10067_023_06548_1 crossref_primary_10_1515_rir_2024_0028 crossref_primary_10_1111_1756_185X_70066 |
| Cites_doi | 10.1007/s00296-016-3628-7 10.1002/acr.23281 10.1378/chest.09-0444 10.1002/1529-0131(199805)41:5<817::AID-ART7>3.0.CO;2-S 10.1002/art.27425 10.1002/art.27405 10.1002/art.22120 10.3899/jrheum.091432 10.3899/jrheum.080724 10.3899/jrheum.200863 10.1371/journal.pone.0157360 10.1111/1756-185X.13996 10.1136/ard.2007.079913 10.1007/s12016-018-8672-5 10.1002/acr.21762 10.1002/art.27584 10.1016/S0140-6736(16)30173-8 10.1186/ar2591 10.1186/s13075-017-1457-z 10.1136/annrheumdis-2015-207524 10.1136/ard.2010.138461 10.1038/nrdp.2018.1 10.1080/03009740802241717 10.1001/jama.2018.13103 10.1097/CM9.0000000000001517 |
| ContentType | Journal Article |
| Copyright | Lippincott Williams & Wilkins Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © Wanfang Data Co. Ltd. All Rights Reserved. Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. 2022 |
| Copyright_xml | – notice: Lippincott Williams & Wilkins – notice: Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. – notice: Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. – notice: Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. 2022 |
| CorporateAuthor | CREDIT Co-Authors |
| CorporateAuthor_xml | – name: CREDIT Co-Authors |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 2B. 4A8 92I 93N PSX TCJ 5PM DOA |
| DOI | 10.1097/CM9.0000000000002110 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Database Suite (ProQuest) ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) PubMed Central (Full Participant titles) DOAJ: Directory of Open Access Journal (DOAJ) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitle_FL | Chinese registry of rheumatoid arthritis (CREDIT) V: sex impacts rheumatoid arthritis in Chinese patients |
| EISSN | 2542-5641 |
| EndPage | 2217 |
| ExternalDocumentID | oai_doaj_org_article_11560855f93a4dffb1f5efc7aa4c8d5a PMC9771299 zhcmj202218008 36103962 10_1097_CM9_0000000000002110 00029330-202209200-00008 |
| Genre | Journal Article |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GrantInformation_xml | – fundername: Chinese National Key Technology R&D Program, Ministry of Science and Technology; Beijing Municipal Science and Technology Commission; CAMS Innovation Fund for Medical Sciences (CIFMS) funderid: (Nos. 2017YFC0907601, 2017YFC0907602, and 2017YFC0907603); (Nos. Z201100005520022, 23, and 25-27); (No. 2021-I2M-1-005) |
| GroupedDBID | --- -05 -0E 0R~ 29B 2WC 40I 5GY 5RE 5VR 5VS 6J9 7X7 88E 8FI 8FJ 92F 92I 92M AAAAV AAHPQ AAIQE AASCR ABASU ABCQX ABDIG ABUWG ABVCZ ABZZY ACGFO ACGFS ACILI ACXJB ADGGA ADHPY ADPDF AENEX AFBFQ AFDTB AFKRA AHMBA AHQNM AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ ALIPV ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BENPR BPHCQ BQLVK BVXVI CCEZO CCPQU CHBEP CIEJG CW9 DIK DIWNM EBS EEVPB EJD F5P FA0 FCALG FRP FYUFA GNXGY GQDEL GROUPED_DOAJ GX1 HLJTE HMCUK HYE IAO IHR IKREB IPNFZ JUIAU KQ8 L7B M1P M48 OK1 OPUJH OVD OVDNE OVEED OXXIT P2P P6G PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RIG RLZ RNS RPM RT5 S.. T8U TCJ TEORI TGQ TR2 TSPGW U1F U5O UKHRP W2D WFFXF XSB AAYXX CITATION OVT PJZUB PPXIY 3V. ABXLX CGR CUY CVF ECM EIF NPM Q-- Q-4 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI 7X8 -SE -S~ .55 .GJ 2B. 4A8 53G 93N 9D9 9DE ADRAZ AFUIB AHVBC C1A CAJEE H13 IHW INH INR ITC PMFND PSX PV9 R-E RZL U1G U5E X7J X7M ZGI ZXP 5PM PUEGO |
| ID | FETCH-LOGICAL-c5788-984982c2fbe13c9fb77cae938089e103511349de79c5fdbe955ce4db753f3e573 |
| IEDL.DBID | DOA |
| ISSN | 0366-6999 2542-5641 |
| IngestDate | Wed Aug 27 01:27:56 EDT 2025 Thu Aug 21 18:40:18 EDT 2025 Thu May 29 04:10:17 EDT 2025 Fri Jul 11 11:11:12 EDT 2025 Fri Jul 25 09:34:44 EDT 2025 Wed Feb 19 02:22:33 EST 2025 Sun Aug 03 02:38:43 EDT 2025 Thu Apr 24 23:04:24 EDT 2025 Fri May 16 03:50:38 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 18 |
| Keywords | Disease activity Comorbidities Rheumatoid arthritis Sex Treatment target |
| Language | English |
| License | Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5788-984982c2fbe13c9fb77cae938089e103511349de79c5fdbe955ce4db753f3e573 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doaj.org/article/11560855f93a4dffb1f5efc7aa4c8d5a |
| PMID | 36103962 |
| PQID | 2754917540 |
| PQPubID | 2042885 |
| PageCount | 8 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_11560855f93a4dffb1f5efc7aa4c8d5a pubmedcentral_primary_oai_pubmedcentral_nih_gov_9771299 wanfang_journals_zhcmj202218008 proquest_miscellaneous_2714656049 proquest_journals_2754917540 pubmed_primary_36103962 crossref_citationtrail_10_1097_CM9_0000000000002110 crossref_primary_10_1097_CM9_0000000000002110 wolterskluwer_health_00029330-202209200-00008 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-September-20 |
| PublicationDateYYYYMMDD | 2022-09-20 |
| PublicationDate_xml | – month: 09 year: 2022 text: 2022-September-20 day: 20 |
| PublicationDecade | 2020 |
| PublicationPlace | China |
| PublicationPlace_xml | – name: China – name: Baltimore – name: Hagerstown, MD |
| PublicationTitle | Chinese medical journal |
| PublicationTitleAlternate | Chin Med J (Engl) |
| PublicationTitle_FL | Chinese Medical Journal |
| PublicationYear | 2022 |
| Publisher | Lippincott Williams & Wilkins Lippincott Williams & Wilkins Ovid Technologies National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology State Key Laboratory of Complex Severe and Rare Diseases Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China%Department of Rheumatology, the First People’s Hospital of Yunnan Province, Kunming, Yunnan 650032, China%Department of Rheumatology, the Affiliated Hospital of Inner Mongolia Medical College, Hohhot, Inner Mongolia 010050, China%Department of Rheumatology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China%Department of Rheumatology and Immunology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang 830001, China%Department of Rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China%Department of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, China%Department of Rheumatology, The First Affiliated Hospital of Guangxi Medical University, Manning, Guangxi 530021, China%Department of Rheumatology, The First Hospital of Jilin University, Changchun, Jilin 130021, China%Department of Epidemiology and Bio-Statistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing 100005, China Wolters Kluwer |
| Publisher_xml | – name: Lippincott Williams & Wilkins – name: Lippincott Williams & Wilkins Ovid Technologies – name: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College – name: National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology – name: State Key Laboratory of Complex Severe and Rare Diseases – name: Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China%Department of Rheumatology, the First People’s Hospital of Yunnan Province, Kunming, Yunnan 650032, China%Department of Rheumatology, the Affiliated Hospital of Inner Mongolia Medical College, Hohhot, Inner Mongolia 010050, China%Department of Rheumatology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China%Department of Rheumatology and Immunology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang 830001, China%Department of Rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China%Department of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, China%Department of Rheumatology, The First Affiliated Hospital of Guangxi Medical University, Manning, Guangxi 530021, China%Department of Rheumatology, The First Hospital of Jilin University, Changchun, Jilin 130021, China%Department of Epidemiology and Bio-Statistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing 100005, China – name: Wolters Kluwer |
| References | Aletaha (R4-20250603) 2018; 320 Jin (R12-20250603) 2017; 19 Smolen (R1-20250603) 2016; 388 Bongartz (R28-20250603) 2010; 62 Aletaha (R15-20250603) 2010; 69 Sokka (R21-20250603) 2009; 11 Favalli (R18-20250603) 2019; 56 Myasoedova (R3-20250603) 2010; 62 Xiang (R13-20250603) 2020; 23 Gossec (R25-20250603) 2005; 32 Iikuni (R20-20250603) 2009; 36 Weyand (R23-20250603) 1998; 41 Yu (R11-20250603) 2018; 36 Radovits (R9-20250603) 2008; 67 Song (R14-20250603) 2021; 134 Twigg (R7-20250603) 2018; 70 Aurrecoechea (R8-20250603) 2017; 37 Tengstrand (R24-20250603) 2004; 31 Kim (R27-20250603) 2009; 136 Rintelen (R10-20250603) 2008; 37 Jawaheer (R19-20250603) 2012; 64 Kronzer (R29-20250603) 2021; 48 Jawaheer (R6-20250603) 2010; 37 Fransen (R30-20250603) 2016; 11 Aletaha (R16-20250603) 2010; 62 Jawaheer (R22-20250603) 2006; 54 Smolen (R2-20250603) 2018; 4 Voulgari (R5-20250603) 2004; 22 Smolen (R17-20250603) 2016; 75 Kuiper (R26-20250603) 2001; 28 |
| References_xml | – volume: 37 start-page: 479 year: 2017 ident: R8-20250603 article-title: Gender-associated comorbidities in rheumatoid arthritis and their impact on outcome: data from GENIRA publication-title: Rheumatol Int doi: 10.1007/s00296-016-3628-7 – volume: 70 start-page: 361 year: 2018 ident: R7-20250603 article-title: Effect of fatigue, older age, higher body mass index, and female sex on disability in early rheumatoid arthritis in the treatment-to-target era publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.23281 – volume: 36 start-page: 836 year: 2018 ident: R11-20250603 article-title: Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis publication-title: Clin Exp Rheumatol – volume: 136 start-page: 1397 year: 2009 ident: R27-20250603 article-title: Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern publication-title: Chest doi: 10.1378/chest.09-0444 – volume: 41 start-page: 817 year: 1998 ident: R23-20250603 article-title: The influence of sex on the phenotype of rheumatoid arthritis publication-title: Arthritis Rheum doi: 10.1002/1529-0131(199805)41:5<817::AID-ART7>3.0.CO;2-S – volume: 22 start-page: 165 year: 2004 ident: R5-20250603 article-title: Early rheumatoid arthritis: does gender influence disease expression? publication-title: Clin Exp Rheumatol – volume: 32 start-page: 1448 year: 2005 ident: R25-20250603 article-title: Influence of sex on disease severity in patients with rheumatoid |arthritis publication-title: J Rheumatol – volume: 31 start-page: 214 year: 2004 ident: R24-20250603 article-title: The influence of sex on rheumatoid arthritis: a prospective study of onset and outcome after 2 years publication-title: J Rheumatol – volume: 62 start-page: 1576 year: 2010 ident: R3-20250603 article-title: Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955–2007 publication-title: Arthritis Rheum doi: 10.1002/art.27425 – volume: 62 start-page: 1583 year: 2010 ident: R28-20250603 article-title: Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study publication-title: Arthritis Rheum doi: 10.1002/art.27405 – volume: 28 start-page: 1809 year: 2001 ident: R26-20250603 article-title: Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis publication-title: J Rheumatol – volume: 54 start-page: 3087 year: 2006 ident: R22-20250603 article-title: Influence of male sex on disease phenotype in familial rheumatoid arthritis publication-title: Arthritis Rheum doi: 10.1002/art.22120 – volume: 37 start-page: 2475 year: 2010 ident: R6-20250603 article-title: Disease progression and treatment responses ina prospective DMARD-naive seropositive early rheumatoid arthritis cohort: does gender matter? publication-title: J Rheumatol doi: 10.3899/jrheum.091432 – volume: 36 start-page: 508 year: 2009 ident: R20-20250603 article-title: The influence of sex on patients with rheumatoid arthritis in a large observational cohort publication-title: J Rheumatol doi: 10.3899/jrheum.080724 – volume: 48 start-page: 656 year: 2021 ident: R29-20250603 article-title: Lifestyle and clinical risk factors for incident rheumatoid arthritis-associated interstitial lung disease publication-title: J Rheumatol doi: 10.3899/jrheum.200863 – volume: 11 start-page: e0157360 year: 2016 ident: R30-20250603 article-title: Rheumatoid arthritis disadvantages younger patients for cardiovascular diseases: a meta-analysis publication-title: PLoS One doi: 10.1371/journal.pone.0157360 – volume: 23 start-page: 1719 year: 2020 ident: R13-20250603 article-title: Chinese registry of rheumatoid arthritis (CREDIT): III. The transition of disease activity during follow-ups and predictors of achieving treatment target publication-title: Int J Rheum Dis doi: 10.1111/1756-185X.13996 – volume: 67 start-page: 1127 year: 2008 ident: R9-20250603 article-title: Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis publication-title: Ann Rheum Dis doi: 10.1136/ard.2007.079913 – volume: 56 start-page: 333 year: 2019 ident: R18-20250603 article-title: Sex and management of rheumatoid arthritis publication-title: Clin Rev Allergy Immunol doi: 10.1007/s12016-018-8672-5 – volume: 64 start-page: 1811 year: 2012 ident: R19-20250603 article-title: Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patients publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.21762 – volume: 62 start-page: 2569 year: 2010 ident: R16-20250603 article-title: 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative publication-title: Arthritis Rheum doi: 10.1002/art.27584 – volume: 388 start-page: 2023 year: 2016 ident: R1-20250603 article-title: Rheumatoid arthritis publication-title: Lancet doi: 10.1016/S0140-6736(16)30173-8 – volume: 11 start-page: R7 year: 2009 ident: R21-20250603 article-title: Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study publication-title: Arthritis Res Ther doi: 10.1186/ar2591 – volume: 19 start-page: 251 year: 2017 ident: R12-20250603 article-title: Chinese registry of rheumatoid arthritis (CREDIT): II. Prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis publication-title: Arthritis Res Ther doi: 10.1186/s13075-017-1457-z – volume: 75 start-page: 3 year: 2016 ident: R17-20250603 article-title: Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2015-207524 – volume: 69 start-page: 1580 year: 2010 ident: R15-20250603 article-title: 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative publication-title: Ann Rheum Dis doi: 10.1136/ard.2010.138461 – volume: 4 start-page: 18001 year: 2018 ident: R2-20250603 article-title: Rheumatoid arthritis publication-title: Nat Rev Dis Primers doi: 10.1038/nrdp.2018.1 – volume: 37 start-page: 410 year: 2008 ident: R10-20250603 article-title: SDAI/CDAI levels in rheumatoid arthritis patients are highly dependent on patient's pain perception and gender publication-title: Scand J Rheumatol doi: 10.1080/03009740802241717 – volume: 320 start-page: 1360 year: 2018 ident: R4-20250603 article-title: Diagnosis and management of rheumatoid arthritis: a review publication-title: JAMA doi: 10.1001/jama.2018.13103 – volume: 134 start-page: 1465 year: 2021 ident: R14-20250603 article-title: Chinese registry of rheumatoid arthritis: IV. Correlation and consistency of rheumatoid arthritis disease activity indices in China publication-title: Chin Med J doi: 10.1097/CM9.0000000000001517 |
| SSID | ssj0025576 ssib001521049 ssib051457378 ssib044732928 ssib008142972 ssib038074633 ssib017628699 ssib058574914 ssib020751800 ssib001103466 ssib022315857 ssib000827134 ssib006703066 ssib058492515 ssib051368197 |
| Score | 2.3779562 |
| Snippet | The impact of sex on the clinical manifestations of rheumatoid arthritis (RA) were diversely reported in the literature. The Chinese Registry of rhEumatoiD... Background:The impact of sex on the clinical manifestations of rheumatoid arthritis (RA) were diversely reported in the literature. The Chinese Registry of... Background::The impact of sex on the clinical manifestations of rheumatoid arthritis (RA) were diversely reported in the literature. The Chinese Registry of... Background:. The impact of sex on the clinical manifestations of rheumatoid arthritis (RA) were diversely reported in the literature. The Chinese Registry of... |
| SourceID | doaj pubmedcentral wanfang proquest pubmed crossref wolterskluwer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 2210 |
| SubjectTerms | Age Anti-inflammatory agents Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - drug therapy C-reactive protein Cardiovascular disease Coronary vessels Drugs East Asian People Female Females Humans Lung diseases Male Original Patients Peptides Proteins Registries Remission (Medicine) Rheumatism Rheumatoid arthritis Rheumatology Severity of Illness Index Sexes Stroke Stroke - drug therapy Values Variables Vein & artery diseases |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection (ProQuest) dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELagCMQF8SyBAkbiAIeoiR9xzAXB0qoglQNq0d4i27G7yyMpm66K-PXMJM4uCxWstJf1JPLa39gznvE3hDwLwvBSCp_CV6QiaJtahYmuteGZzZEApmf7_FAcHIv3UzmNB25dTKsc18R-oa5bh2fku0yBJwN7nchenX5PsWoURldjCY3L5ApSl6HzpaZrh0tKFWOVRVqAJTRendNqd3KoB-rC-EE_aGNr6hn8LzI7_86evHpummCaE2g5bzHG3X3pU9x_26j2b5Ib0cKkrwdI3CKXfHObXDuMMfQ7ZI4ls33nKdZkwFJvtA10MfNLsF3beU0BS7Oe6Yg-n3zce_vu6AX99JJ2_gcdblR2FwvPGzq-OHK1dnfJ8f7e0eQgjQUXUgeKCwtfKXTJHAvW59zpYJVyxmteZqX2eR9z5ELXXmknQ229ltJ5UVtweQL3UvF7ZKtpG3-fUF3oWhTB2jpguXWuAQHcZ8w56ZmzIiF8HOvKRTZyLIrxtRqj4jBD1Z8zlJB09dTpwMbxH_k3OI0rWeTS7n9oFydVVE3wgcDqK6UMmhtRh2DzIH1wyhjhylqahOyMIKiignfVGo4JebpqBtXEeItpfLtEmRzZ6MAHS8j2gJlVT3iBMfiCJURtoGmjq5stzXzW03-DxQ5GGrzzScTdulc_Z-7bZwZmWQ5-QAmjtYHHarhai6PE8BwrRclMs4FbICsf_PuPPiTX8QFMlmHZDtk6Wyz9I7DIzuzjXu1-AQUOLn0 priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZKEYgL4k2ggJE4wCEo8SOOkRCCpVVBWg6oi3qLYsfuLpQENl218OuZSZzAwiIurJTLeuJY45n4m4z9DSGPvCh5LoWL4RKx8NrERuFG16rkiUmRAKZj-3yX7c_E20N5uEWGmq1Bge3G0A7rSc2Wx0_Pvn57AQ7_fCBgnEx1T0MYfhjTnCPnYW1SWMxhKsa8AuBnFbKXWZwBNhoO0_2ll7XFquP03wRE_9xPeeG0rH1ZH0HLaYNZ7_ZTt-n9l6Vr7wq5HDAnfdkbyVWy5epr5OI0ZNWvkwUW0Xato1ilAYu_0cbT5dytAM02i4qCdc077iP6ePJ-9_Wbgyf0wzPaujPan7FsNwsvajp0HNhb2xtktrd7MNmPQwmG2IIrw6swFzpnlnnjUm61N0rZ0mmeJ7l2aZeF5EJXTmkrfWWcltI6URkIgjx3UvGbZLtuanebUJ3pSmTemMpjAXauwSa4S5i10jFrRET4oOvCBn5yLJNxXAx5cpih4vcZikg83vWl5-f4h_wrnMZRFtm1uz-a5VERnBWiIsCBuZRe81JU3pvUS-etKkth80qWEdkZjKAYLLZgCkJtAGMCnvFwbAZnxQxMWbtmhTIp8tNBVBaRW73NjCPhGWblMxYRtWZNa0Ndb6kX844QHDA8wDbo80Gwu5-j-j63nz8yAGopRAY5aGvNHov-sC1qieGXrRglE816toEkv_M_tHWXXMJucZMNS3bI9sly5e4Bkjsx9zvn_AEnIT93 priority: 102 providerName: Scholars Portal |
| Title | Chinese registry of rheumatoid arthritis (CREDIT) V: sex impacts rheumatoid arthritis in Chinese patients |
| URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00029330-202209200-00008 https://www.ncbi.nlm.nih.gov/pubmed/36103962 https://www.proquest.com/docview/2754917540 https://www.proquest.com/docview/2714656049 https://d.wanfangdata.com.cn/periodical/zhcmj202218008 https://pubmed.ncbi.nlm.nih.gov/PMC9771299 https://doaj.org/article/11560855f93a4dffb1f5efc7aa4c8d5a |
| Volume | 135 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdgCMQL4pvAKEbiAR6iJbEd27yx0jGQOqFpQ32LYsem5SNBy6oh_nruEqcsMGkvVEoe6qvrnM_173rn3xHywvOSKcFdDBePudcmNhITXauSJSZFApiO7fMg3z_mHxZica7UF-aE9fTAveJ2Ujzqq4TwmpW88t6kXjhvZVlyqyrRQSPY8wZnKrhaQsgQpczjHDDQcGhOy53pXPekheGFHtBoU-q4-y8CnP_mTV4_K2tf1p-h5azB6Hb7tUtuP7dF7d0mtwK2pG_6Z7pDrrj6LrkxD9Hze2SFxbJd6yhWY8Aib7Tx9GTp1oBam1VFQRnLjuOIvpwezt6-P3pFP72mrftJ-7OU7cXCq5oOHQeW1vY-Od6bHU3341BqIbawZOEnT3GtMpt541JmtTdS2tJpphKlXdpFGxnXlZPaCl8Zp4WwjlcGnB3PnJDsAdmqm9o9IlTnuuK5N6byWGidaZh75pLMWuEya3hE2KDrwgYeciyH8a0Y4uEwQ8XfMxSRePOpHz0PxyXyuziNG1lk0e7eANsqgm0Vl9lWRLYHIyjC0m6LTIJLDaCLw3c83zTDosRIS1m7Zo0yKfLQgfcVkYe9zWxGwnKMvudZROTImkZDHbfUq2VH_A1YHeAZ9Pks2N2fUf1a2u9fMgBkKXgACrQ1sseiP1SLWsrwH6wYJROd9awCiXr8P7T1hNzEbjGZJku2ydbpydo9BcR2aibkqlzICbm2Ozv4eDjplirc3y1SuM-5-g1ZGTx_ |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGEJcXxJ3AYEYCCR6iJb4kMRJC0G1q2boHtKG-hdix13JJRrOqwI_iN3JOLi2FCZ5WqS_1ieX6fLbPyTn-DiFPnMh4IoX14St84ZT2dYyJrnnGAx0iAUzN9nkQ9Y_E25EcrZGf3V0YTKvs9sR6o85Lg-_It1gMngycdSJ4dfLVx6pRGF3tSmg0sNiz3-fgslUvB9ug36eM7e4c9vp-W1XAN4BOWN2JUAkzzGkbcqOcjmOTWcWTIFE2rANrXKjcxspIl2urpDRW5BrsesetjDn0e4FchIM3wBTCeLR08KSM29ho5EdgeXVX9VS81Ruqhiqx_aDftXIU1hUDzjJz_87WvDTPCpcVx9AyLzGmXn2qU-p_Oxh3r5NrrUVLXzcQvEHWbHGTXB62MftbZIIlum1lKdaAwNJytHR0OrYzsJXLSU4Bu-OaWYk-673b2R4cPqfvX9DKfqPNDc7qbOFJQbuOW27Y6jY5OhdV3CHrRVnYe4SqSOUiclrnDsu7cwWI4zZgxkjLjBYe4d1cp6ZlP8ciHJ_TLgoPGkr_1JBH_MVTJw37x3_k36AaF7LI3V3_UE6P03YrAJ8LrMxESqd4JnLndOikdSbOMmGSXGYe2ehAkLYbSpUu4e-Rx4tm2AowvpMVtpyhTIjsd-DzeeRug5nFSHiEMf-IeSReQdPKUFdbism4phsHDwGMQuhzs8XdclQ_xubLRwZmYAh-RwKztYLHtLnKi7PE8L2Zj5KBYg2XQZDc__cf3SRX-ofD_XR_cLD3gFzFhzFRhwUbZP10OrMPwRo81Y_qJUjJh_Ne878A6mFrBg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELfGJiZeEN8UBgsSiuAhUxLbSYzUh9GmbIN1E93GeIpix17LRzI1LQP-eu7yUSgMISpVreqLa9l3zu9y598R8tSwlEacaQfezGFGSEeGmOiapdSVHhLAVGyfw2DnmO2d8tMV0qYO4eGz8nwLP6ptGr9gORz0C4-6eyO7N-p139vD-N2oO7QPt1_F1WNqTJKwD_uD7je73y2-mJndP-i2_Iy9fVGzFDYvdHmukLUoClwwjLWDkzjuL3w0zsMmvBk4AYCn9rTdX_pZuptVpP-XIdU_Ey6vXqS5SfMzaLkoMCxefqyy4n-5tw1ukOsNKLW2ay26SVZ0fous7zdh99tkglW2daktLOOA1eGswljTsZ4D3C0mmQXqN67Ikaxnvbdxf_fouXXywir1V6s-hFleLjzJrbbjht61vEOOB_FRb8dpajQ4Cmwd9sqIichXvpHao0oYGYYq1YJGbiS0V4UpKROZDoXiJpNacK40yyR4SYZqHtK7ZDUvcn2fWCIQGQuMlJnBCu1UgNJQ7fpKce0ryTqEtnOdqIbAHOtofEraQDqsUPL7CnWIs7jqvCbw-If8S1zGhSzSb1c_FNOzpLFmcJsAKEacG0FTlhkjPcO1UWGaMhVlPO2QjVYJkmZPKBM_BF8c0BqD_3iyaAZrxhBNmutijjIeEtiB29Yh92qdWYyEBhi2D_wOCZe0aWmoyy35ZFwxhgPIB1wHfW42evdzVN_H6vMHH5CcB65DBLO1pI9JfRoXZ8nHR18OSrrCr-kI3OjBf8pvknUw0-TN7vD1Q3INGzH3xnc3yOpsOtePAODN5OPGKH8AbQZBeg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chinese+registry+of+rheumatoid+arthritis+%28CREDIT%29+V%3A+sex+impacts+rheumatoid+arthritis+in+Chinese+patients&rft.jtitle=Chinese+medical+journal&rft.au=Nan+Jiang&rft.au=Qin+Li&rft.au=Hongbin+Li&rft.au=Yongfei+Fang&rft.date=2022-09-20&rft.pub=Wolters+Kluwer&rft.issn=0366-6999&rft.eissn=2542-5641&rft.volume=135&rft.issue=18&rft.spage=2210&rft.epage=2217&rft_id=info:doi/10.1097%2FCM9.0000000000002110&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_11560855f93a4dffb1f5efc7aa4c8d5a |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzhcmj%2Fzhcmj.jpg |